In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management

Authors: Robert M. Rifkin, Saulius K. Girnius, Stephen J. Noga, Ruemu E. Birhiray, Suman Kambhampati, Sudhir Manda, Roger M. Lyons, Habte A. Yimer, Dasha Cherepanov, Eric Lloyd, Presley Whidden, Joshua Richter

Source: Blood Cancer Journal, Vol 13, Iss 1, Pp 1-12 (2023)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2044-5385

Access URL: https://doaj.org/article/4610ad81300445efb624a0ed2b1b1a3e

PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6

Authors: Saulius K. Girnius, Joshua Richter, Roger M. Lyons, Kimberly Bogard, Sudhir Manda, Ruemu E. Birhiray, Habte A. Yimer, Kim Tran, Suman Kambhampati, Jyoti Arora, Stephen Noga, Robert Rifkin

Source: HemaSphere, Vol 7, p e149880d (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000975148.14988.0d; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/328dc04e4b344064a84c686181fa6753

Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019

Authors: Nicole Balmaceda, Muhammad Aziz, Viveksandeep Thoguluva Chandrasekar, Brian McClune, Suman Kambhampati, Leyla Shune, Al-Ola Abdallah, Faiz Anwer, Aneela Majeed, Muzaffar Qazilbash, Siddhartha Ganguly, Joseph McGuirk, Ghulam Rehman Mohyuddin

Source: BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)

Subject Terms: Multiple myeloma, Proteasome inhibitors, Anti-CD38, Cytotoxic therapy, Infection, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/cb3bb2d95ce64ff995577383bb9c055e

Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway

Authors: Inamul Haque, Arnab Ghosh, Seth Acup, Snigdha Banerjee, Kakali Dhar, Amitabha Ray, Sandipto Sarkar, Suman Kambhampati, Sushanta K. Banerjee

Source: BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)

Subject Terms: Leptin, CCN5, Breast cancer, Proliferation, Invasion and migration, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s12885-018-3993-6; https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/338eeec208c0467395d89d777d834be6

Comparison of Bone Marrow Biopsy Specimens Obtained Using a Motorized Device and Manual Biopsy Systems

Authors: Catherine A Glennon, Janet M Woodroof, Suman Kambhampati, Alexis C Battershell, Serena R O'Connor, Kiley B Roberts

Source: Asia-Pacific Journal of Oncology Nursing, Vol 5, Iss 4, Pp 394-398 (2018)

Subject Terms: Bone marrow aspiration and biopsy, crush artifact, manual approach, motorized device, pathology, quality, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Nursing, RT1-120

File Description: electronic resource

Relation: http://www.apjon.org/article.asp?issn=2347-5625;year=2018;volume=5;issue=4;spage=394;epage=398;aulast=Glennon; https://doaj.org/toc/2347-5625; https://doaj.org/toc/2349-6673

Access URL: https://doaj.org/article/3e029a6ab2ca4526b90d88c89912eca9

A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia

Authors: Gregory A. Reed, Gary J. Schiller, Suman Kambhampati, Martin S. Tallman, Dan Douer, Mark D. Minden, Karen W. Yee, Vikas Gupta, Joseph Brandwein, Yulia Jitkova, Marcela Gronda, Rose Hurren, Aisha Shamas‐Din, Andre C. Schuh, Aaron D. Schimmer

Source: Cancer Medicine, Vol 5, Iss 11, Pp 3031-3040 (2016)

Subject Terms: Cox‐1, Cox‐4, mitochondrial protein synthesis, pharmacodynamics, pharmacokinetics, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/a10c49769cfe4648b838a6df9401d3ca

Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia

Authors: Bruno C. Medeiros, Kelly McCaul, Suman Kambhampati, Daniel A. Pollyea, Rajat Kumar, Lewis R. Silverman, Andrea Kew, Lalit Saini, CL Beach, Ravi Vij, Xiwei Wang, Jim Zhong, Robert Peter Gale

Source: Haematologica, Vol 103, Iss 1 (2018)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://haematologica.org/article/view/8308; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721

Access URL: https://doaj.org/article/996424bd79e3482db71368b705848b5c

Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.

Authors: Jill M Hamilton-Reeves, Snigdha Banerjee, Sushanta K Banerjee, Jeffrey M Holzbeierlein, J Brantley Thrasher, Suman Kambhampati, John Keighley, Peter Van Veldhuizen

Source: PLoS ONE, Vol 8, Iss 7, p e68331 (2013)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC3710024?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/ba27cfdb1e514e68bc267ce6da9bbfde

CAR-T cell therapy in relapsed or refractory multiple myeloma and access in Turkey.

Authors: Hakan, Goker, Engin, Kelkitli, Elifcan, Karakulak Aladag, Haluk, Demiroglu, Mehmet, Turgut, Suman, Kambhampati, Maxwell, Krem

Source: Frontiers in Medicine; 2024, p1-7, 7p

Jak family of kinases in cancer.

Authors: Amit Verma, Suman Kambhampati, Simrit Parmar, Leonidas C. Platanias

Source: Cancer & Metastasis Reviews; Dec2003, Vol. 22 Issue 4, p423-434, 12p

Pegylated Liposomal Doxorubicin (Doxil®), Dexamethasone and Low Dose Thalidomide (DDt) as Therapy for Newly Diagnosed Multiple Myeloma.

Authors: Deauna-Limayo, Delva, Aljitawi, Omar S., Mayo, Mathew ^*, Bodensteiner, David C., Ganguly, Siddhartha, Skikne, Barry S., Suman, Kambhampati

Source: In Blood 16 November 2005 106(11):5164-5164